DePuy Synthes, Inc.

United Statesjnjmedicaldevices.com/en-US/depuy-synthes

DePuy Synthes, Inc. is a global medical device company focused on orthopaedics. It develops and supplies implants, instruments, and digital surgery solutions used in the treatment of trauma, degenerative conditions, deformities, and other musculoskeletal disorders.

The company’s portfolio spans trauma fixation systems (plates, screws, nails), joint reconstruction (hip, knee, shoulder), spine and craniomaxillofacial solutions, sports medicine devices, powered surgical instruments, and related biomaterials and bone substitutes. DePuy Synthes supports the full surgical workflow—from preoperative planning and navigation to intraoperative tools and postoperative care—serving hospitals, ambulatory surgery centers, and surgeons worldwide. Its products incorporate a range of advanced materials and surface technologies designed to enhance implant performance and tissue integration, with development and manufacturing conducted across multiple global sites under established medical device quality and regulatory standards.

Latest news on DePuy Synthes

15 July 2026
Johnson & Johnson Q2 2026 results and raises 2026 outlook

Quarterly sales topped $25.3B; adjusted net earnings and EPS rose, free cash flow improved, and full-year revenue guidance was raised above $100B for the first time.

14 October 2025
Johnson & Johnson to Spin Off Orthopaedics Business

The separation aims to enhance strategic focus, boost growth, and improve margins, creating a standalone orthopaedics leader, DePuy Synthes.